scienceneutral
Blood Flow and Genes: A Hidden Link to Heart Disease
Friday, May 2, 2025
So, how does Aff3ir-ORF2 work its magic? The answer lies in another gene called Irf5. Irf5 is known to regulate inflammatory processes in the body. The study found that Aff3ir-ORF2 interacts with Irf5. It keeps Irf5 in the cytoplasm, which is the part of the cell outside the nucleus. This interaction stops Irf5 from turning on inflammatory pathways.
The researchers also found that reducing Irf5 levels in mice with low Aff3ir-ORF2 expression almost completely reversed the severe atherosclerosis. This shows just how important the interaction between these two genes is.
But the story doesn't end there. The researchers used a technique called CRISPR/Cas9 to increase Aff3ir-ORF2 levels specifically in the endothelial cells. These are the cells that line the blood vessels. The results were promising. Increasing Aff3ir-ORF2 levels reduced endothelial cell activation and atherosclerosis. This suggests that targeting this gene could be a new way to treat atherosclerosis.
This research opens up new avenues for understanding and treating heart disease. It shows that genes like Aff3ir-ORF2 and Irf5 play a crucial role in the development of atherosclerosis. By understanding these genes better, scientists might find new ways to prevent and treat heart disease. It is a reminder that the body's processes are complex and interconnected. What seems like a small part of the puzzle can have a big impact.
Actions
flag content